South Africa’s first cannabis clinical trial examining the plant’s effectiveness as an alternative to opioids for chronic pain management looks to enrol 300 participants, with the results expected in late 2023.
The Cannabis Research Institute of South Africa (CRI) is sponsoring a year-long study that it hopes will provide credible, reliable, and verifiable data on medicinal cannabis. The clinical trial comes amid South Africa’s perception shift regarding the plant, which has grown since the 2018 Constitutional Court ruling decriminalising private, personal use of cannabis.
– Read the entire article at Business Insider SA.
Original Article
